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Abstract
Bone is formed through the processes of endochondral and intramembranous ossification. In endochondral 
ossification primary mesenchymal cells differentiate to chondrocytes and then are progressively substituted by 
bone, while in intramembranous ossification mesenchymal stem cells (MSCs) differentiate directly into 
osteoblasts to form bone. The steps of osteogenic proliferation, differentiation, and bone homeostasis are 
controlled by various markers and signaling pathways. Bone needs to be remodeled to maintain integrity with 
osteoblasts, which are bone-forming cells, and osteoclasts, which are bone-degrading cells. 
In this review we considered the major factors and signaling pathways in bone formation; these include 
fibroblast growth factors (FGFs), bone morphogenetic proteins (BMPs), wingless-type (Wnt) genes, runt-
related transcription factor 2 (RUNX2) and osteoblast-specific transcription factor (osterix or OSX). 
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Introduction
Bone is formed through the processes of 
endochondral and intramembranous ossification (1). 
In each process mesenchymal progenitors condense 
and initiate developmental programs that include 
chondrogenesis and osteoblastogenesis (2). 
During endochondral ossification, mesenchymal 
cells differentiate into chondrocytes, which form the 
cartilage growth plate. The cartilage growth plate is 
then gradually replaced by bone (3). Most bones in 
the human skeleton are made through endochondral 
ossification (4). These include the long, short, and 
irregular bones (5). Flat bones, including those of the 
skull, facial bones, and pelvis are made by 
intramembranous ossification (4-6). In this process 
mesenchymal stem cells (MSCs) differentiate 
directly into osteoblasts to organized bone (4). 
In both processes, osteoblastic bone formation is 
identical. The synthesis of bone matrix initiates with 
the construction of type 1 collagen via osteoblasts. 
Most extracellular matrix protein of bone is type 1
collagen, which supplies strength and elasticity of 
bone, and scaffolding for the deposition of other 
matrix components such as hydroxyapatite (7).
Bone homeostasis is controlled by various 
signaling pathways (8). The main pathways that 
participate in osteoblast differentiation include 
members of the fibroblast growth factor (FGF) and 
bone morphogenic protein (BMP) families and the 
Wnt signaling pathway (8, 9). Correspondingly, two 
important transcription factors, runt-related 
transcription factor 2 (RUNX2) and osteoblast-
specific transcription factor (osterix or OSX), are 
expressed in osteoblasts, both of which are essential 
and sufficient for osteoblast differentiation (9, 10). 
Some studies reported that RUNX2 and OSX are not 
sufficient for osteoblast maturation (11); however, it 
is clear that RUNX2 regulate osteogenesis (12).
Bone must be constantly replaced to preserve its 
strength and integrity. Bone remodeling is organized 
by two conflicting activities; these are bone formation 
by osteoblasts, which produce the organic bone 
matrix, and bone resorption by osteoclasts, which 
dissolve bone mineral and extracellular matrix (7, 
13). Osteogenesis and angiogenesis are two closely-
associated processes involved in bone growth, 
remodeling, and repair (6). Osteoclasts activate 
angiogenesis in vitro via expression of proangiogenic 
